(2-Pyridin-2-yl-benzoimidazol-1-yl)-acetic acid, 95.0%, 5g

Molybdenum ICP standard solution, ROTI®Star, 10000 mg/l Mo, density (D) 1.019 g/cm³

2-Amino-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95%, 500mg

(S)-1-(2-Chlorophenyl)-2,2,2-trifluoroethanamine hydrochloride, 95%, 100mg

Methyl 2-(2-methoxypyridin-4-yl)acetate, 97%, 1g

2-(4-Bromothiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

(R)-2-((Benzyloxy)methyl)oxirane, 98.0%, 10g

tert-Butyl 2-formyl-4h,5h,6h,7h-thieno[3,2-c]pyridine-5-carboxylate, 95+%, 500mg

6-Aminopicolinic acid methyl ester, 95.0%, 5g

4,4-Bipiperidine, 95.0%, 1g

Phorbol-12-myristate-13-acetate, ROTICHROM® HPLC, 1 mg, glass packaging

2-(methylamino)nicotinaldehyde, 95.0%, 1g

(S)-4,5,6,7-Tetrahydro-benzothiazole-2,6-diamine, 97.0%, 5g